| Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Study Connects Agent Orange Exposure to Earlier and More Severe Cases of Myelodysplastic Syndrome

Summary
Many veterans and doctors have long questioned whether Agent Orange (AO) exposure during the Vietnam War contributed to cases of myelodysplastic syndrome (MDS), a type of blood cancer.

The contaminated chemical is linked to several cancers, but a link to MDS was unclear. This created real barriers for exposed veterans with MDS who are seeking care and disability benefits.

Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia

Highlights
    
Heme biosynthesis enzymes are variably suppressed in AML
    
Heme levels are linked with altered leukemic transcriptional programs via BACH1
    
Heme biosynthesis is a selective dependency in AML, both in vitro and in vivo
    
Heme starvation disrupts complex IV, inducing copper accumulation and cuproptosis

Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy

Key Points
Ivosidenib, venetoclax ± azacitidine either rapidly selects evolved, resistant leukemic clones or eradicates leukemic clones.

Resistant clones express RNA signatures of stemness, branched-chain amino acid metabolism, and menin targets.

Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry

Author(s): 
Bente Houtman , Adele Taylor , Corine Van Marrewijk , Alexandra Smith , Pierre Fenaux , Catherine Cargo , Argiris Symeonidis , Moshe Mittelman , Reinhard Stauder , Jaroslav Čermák , Guillermo Sanz , Eva Hellström-Lindberg
Primary Author: 
Bente Houtman
Journal Title: 
Haematologica
Original Publication Date: 
Oct 2025

Infections are an important cause of morbidity and mortality in patients with lower-risk

Bone Marrow Disease(s): 

Optimal timing of allogeneic hematopoietic stem cell transplant in MDS

Author(s): 
Kristin Rathje , Nicolaus Kröger
Primary Author: 
Kristin Rathje
Journal Title: 
Leukemia & Lymphoma
Original Publication Date: 
Oct 2025

Myelodysplastic neoplasms (MDS) are clonal hematopoietic disorders characterized by ineffective hematopoiesis, dysplasia, and a significant risk of progression to

Bone Marrow Disease(s): 

A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCs

Highlights
•    
Single-cell RNA-sequencing performed on 16 lower-risk myelodysplastic syndrome (LR-MDS) bone marrow-derived mononuclear cells (BMMCs)
•    
A 30-gene signature distinguishes LR-MDS hematopoietic stem and progenitor cells (HSPCs) from Healthy HSPCs
•    
Vesicular trafficking-related gene modules are enriched in MDS
•